Ilika Q&A: CFO Steve Boydell discusses the £15 million placing in more detail (LON:IKA)

stereax

Ilika plc (LON:IKA) Chief Financial Officer Steve Boydell caught up with DirectorsTalk for an exclusive interview to discuss the placing of £15 million in more detail.

Q1: On Friday, Ilika announced that it had completed a placing of £15 million, what have the funds been raised for?

A1: The funding has been raised to drive the company’s roadmap across its portfolio of solid state battery programmes.

In rough numbers, £4 million has been earmarked to support the transfer of our miniature batteries, branded Stereax, into a third party fabrication facility. A further £4 million provides us with the option to dual-source this production at another fab and the balance is to support our contribution to our larger format battery programme, which we’ve branded Goliath, and enables us to strengthen the balance sheet and provide additional working capital.

Q2: Has the funding been raised mostly from new or existing shareholders?

A2: We’ve received strong support from our existing investor base who have taken approximately 60% of the placing with the balance coming from a small number of new holders, one of whom is a tier 1 investor who will have a disclosable 5% holding in the company once the deal has been completed.

Q3: Ilika has developed quite a retail investor base, will these investors be able to participate?

A3: Yes, so addition to the placing, we have announced an open offer of up to an additional £2 million. This has been done to enable all of our shareholders to participate on the same terms as the institutions as we recognise how important these investors are in supporting the company as we grow the company and commercialise our solid state battery technology.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Ilika builds the manufacturing path for Goliath solid-state batteries

Ilika is building the manufacturing and licensing pathway needed to move its Goliath solid-state battery technology towards larger-scale commercial production.

Ilika: Stereax revenue growth and Goliath opportunities ahead

Morphose Capital Partners’ Dr Tom McColm discusses Ilika’s FY26 results, the outlook for Stereax commercial revenues, progress with Goliath and potential opportunities in automotive, defence and e-bikes.

Ilika CEO highlights Stereax revenue growth and Goliath defence interest

Ilika CEO Graeme Purdy discusses Stereax product revenue, planned M300 battery deliveries, Goliath 10Ah development, EV market trends and rising demand from the defence sector.

Ilika plc reaches a commercial turning point as new markets emerge for Stereax and Goliath (video)

Dr Tom McColm of Morphose Capital Partners explains why the company may be approaching an important commercial inflection point.

Ilika plc: Stereax Revenue Arrives as Goliath Draws Defence Interest (video)

Ilika plc CEO Graeme Purdy outlines how Stereax has started generating product-related revenue, why M300 battery deliveries remain on track and how Goliath’s 10Ah prototype is opening new opportunities in defence and sovereign battery supply.

Ilika builds commercial momentum across Stereax and Goliath batteries

Ilika Plc reports annual results for the year ended 30 April 2026, highlighting progress on its Stereax medical battery line and Goliath large-format batteries for EV, defence and consumer applications. The company began Stereax production and deliveries, shipped larger Goliath prototypes, secured further grant funding and raised £5 million post-period to accelerate commercialisation.

Search